Healthcare Improvement Scotland, SHTG team December 2017
- Key points
- There is insufficient evidence to recommend the routine use of FDG PET-CT imaging in the staging or re-staging of patients with penile or testicular cancer in NHSScotland.
- No evidence was identified which assessed the cost effectiveness of FDG PET-CT in patients with male genitourinary cancers. Therefore, no conclusions can be drawn about the cost effectiveness of FDG PET-CT in this patient group.
- The diagnostic accuracy of CT imaging as a comparator may be underestimated as reported CT imaging methods often differed from how CT imaging is performed in clinical practice in Scotland.
- Further research may be required to consider whether patient preferences could be considered alongside the risks involved in exposure to different imaging modalities.
